	US 12,358,859 B2
	Series of compounds for treatment of skin diseases and other conditions
Sandip K. Nandy, Olympia, WA (US); Teresa Horm, Renton, WA (US); and Kelly Rose Dawkins, Tacoma, WA (US)
Assigned to Unigen, Inc., Tacoma, WA (US)
Filed by Unigen, Inc., Tacoma, WA (US)
Filed on Aug. 14, 2022, as Appl. No. 17/887,480.
Application 17/887,480 is a continuation of application No. 16/600,536, filed on Oct. 13, 2019, granted, now 11,414,366.
Claims priority of provisional application 62/745,380, filed on Oct. 14, 2018.
Prior Publication US 2022/0411356 A1, Dec. 29, 2022
Int. Cl. C07C 39/20 (2006.01); A23B 2/746 (2025.01); A23B 7/154 (2006.01); A61P 17/10 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); A61P 35/00 (2006.01); C07C 59/54 (2006.01); C07C 233/91 (2006.01); C07D 213/16 (2006.01); C07D 213/30 (2006.01)

CPC C07C 39/20 (2013.01) [A23B 2/746 (2025.01); A23B 7/154 (2013.01); A61P 17/10 (2018.01); A61P 29/00 (2018.01); A61P 31/04 (2018.01); A61P 35/00 (2018.01); C07C 59/54 (2013.01); C07C 233/91 (2013.01); C07D 213/16 (2013.01); C07D 213/30 (2013.01); A23V 2002/00 (2013.01); C07B 2200/09 (2013.01)]

8 Claims

1. A compound selected from the group consisting of (E)-3-(3,7-dimethylocta-1,6-dienyl) pyridine (12); (E)-2-(3,7-dimethylocta-1,6-dienyl) pyridine (13), (E)-5-(3,7-dimethylocta-1,6-dienyl)-2-methoxypyridine (14).